2-氰基苯基氨基甲酸叔丁酯 | 163229-43-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氰基苯基氨基甲酸叔丁酯
• 英文名称: tert-butyl (2-cyanophenyl)carbamate
• 英文别名: tert-butyl N-(2-cyanophenyl)carbamate
• CAS: 163229-43-4
• 化学式: C₁₂H₁₄N₂O₂
• 分子量: 218.255
• InChiKey: CEYTZDSWLJPPRT-UHFFFAOYSA-N

物化性质

• 熔点：
  74-77°C
• 沸点：
  165 °C(Press: 2 Torr)
• 密度：
  1.12±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  62.1
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2926909090

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : N-Boc-2-aminobenzonitrile
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 163229-43-4

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Skin irritation (Category 2), H315
Eye irritation (Category 2), H319
Chronic aquatic toxicity (Category 2), H411
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xi, N Irritant, Dangerous for the R36, R38, R51/53
environment
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
Causes skin irritation.
Causes serious eye irritation.
Toxic to aquatic life with long lasting effects.
Precautionary statement(s)
Avoid release to the environment.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Formula : C12H14N2O2
Molecular Weight : 218,25 g/mol
CAS-No. : 163229-43-4
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
N-Boc-2-aminobenzonitrile
Skin Irrit. 2; Eye Irrit. 2; -
Aquatic Chronic 2; H315,
H319, H411
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into
the environment must be avoided.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 74 - 77 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 2,88
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents, Acids and bases
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
Toxic to aquatic life with long lasting effects.
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: 3077 IMDG: 3077 IATA: 3077
UN proper shipping name
ADR/RID: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (N-Boc-2-
aminobenzonitrile)
IMDG: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (N-Boc-2-
aminobenzonitrile)
IATA: Environmentally hazardous substance, solid, n.o.s. (N-Boc-2-aminobenzonitrile)
Transport hazard class(es)
ADR/RID: 9 IMDG: 9 IATA: 9
Packaging group
ADR/RID: III IMDG: III IATA: III
Environmental hazards
ADR/RID: yes IMDG Marine pollutant: yes IATA: yes
Special precautions for user
Further information
EHS-Mark required (ADR 2.2.9.1.10, IMDG code 2.10.3) for single packagings and combination
packagings containing inner packagings with Dangerous Goods > 5L for liquids or > 5kg for solids.

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
Further information
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氰基苯基氨基甲酸叔丁酯 在 盐酸羟胺 、 sodium methylate 、 铁粉 、 溶剂黄146 作用下， 以 甲醇 、 水 为溶剂， 反应 18.0h， 生成 2-aminobenzimidamide
  参考文献：
  名称：

  [EN] NOVEL ANTIPARASITIC COMPOUNDS AND METHODS
  [FR] NOUVEAUX COMPOSÉS ANTIPARASITAIRES ET PROCÉDÉS

  摘要：

  本发明公开了用于治疗或抑制利什曼病和其他寄生原虫疾病的新型化合物。这些化合物能够结合到利什曼原虫的微管蛋白，诱导寄生虫微管聚合，阻碍利什曼细胞分裂，并且具有广泛的抗寄生虫活性。

  公开号：

  WO2021077102A1
• 作为产物：
  描述：

  tert-butyl N-[(E)-4-chloro-4,4-difluoro-3-oxobut-1-enyl]-N-(2-cyanophenyl)carbamate 在 四(二甲氨基)乙烯 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 2-氰基苯基氨基甲酸叔丁酯
  参考文献：
  名称：

  β-氨基乙烯基氯二氟甲基酮与杂芳基醛的铟介导的 Reformatsky 型反应

  摘要：

  铟可以有效地介导一些 β-氨基乙烯基氯二氟甲基酮与一系列杂芳基醛之间的 Reformatsky 型反应，以良好至高产率提供相应的二氟亚甲基化合物。

  DOI：

  10.1055/s-2002-35618

文献信息

• One-Pot Synthesis of 5-Hydroxy-4<i>H</i>-1,3-thiazin-4-ones: Structure Revision, Synthesis, and NMR Shift Dependence of Thiasporine A
  作者：Tobias Seitz、Peng Fu、Franz-Lucas Haut、Lutz Adam、Marija Habicht、Dieter Lentz、John B. MacMillan、Mathias Christmann

  DOI：10.1021/acs.orglett.6b01166

  日期：2016.7.1

  arylthioamides with 3-bromopyruvic acid chloride to 5-hydroxy-4H-1,3-thiazin-4-ones has been developed. The initial condensation affords two regioisomeric thiazolinone intermediates in a temperature-dependent manner. The synthesis of the 2-aminophenylthiazinone derivative led to the revision of the previously proposed structure of thiasporine A. Synthesis of the revised structure and NMR analysis revealed that

  已经开发了将芳基硫酰胺与3-溴丙酮酸酰氯环环化成5-羟基-4 H -1,3-噻嗪-4-酮。初始缩合以温度依赖性方式提供两种区域异构的噻唑啉酮中间体。2-氨基苯基噻嗪酮衍生物的合成导致了先前提出的噻菌素A的结构的修饰。修饰的结构的合成和NMR分析表明，噻菌素A已被分离为羧酸盐。
• [EN] HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS<br/>[FR] MODULATEURS ALLOSTÉRIQUES DES PROTÉINES DU NOYAU DE L'HÉPATITE B
  申请人：UNIV INDIANA RES & TECH CORP

  公开号：WO2015138895A1

  公开（公告）日：2015-09-17

  ABSTRACT The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

  摘要 本公开提供了部分具有对乙型肝炎病毒Cp具有变构效应的化合物。本文还提供了治疗病毒感染（如乙型肝炎）的方法，包括向需要的患者施用所述化合物。
• Transnitrilation from Dimethylmalononitrile to Aryl Grignard and Lithium Reagents: A Practical Method for Aryl Nitrile Synthesis
  作者：Jonathan T. Reeves、Christian A. Malapit、Frederic G. Buono、Kanwar P. Sidhu、Maurice A. Marsini、C. Avery Sader、Keith R. Fandrick、Carl A. Busacca、Chris H. Senanayake

  DOI：10.1021/jacs.5b06136

  日期：2015.7.29

  An electrophilic cyanation of aryl Grignard or lithium reagents, generated in situ from the corresponding aryl bromides or iodides, by a transnitrilation with dimethylmalononitrile (DMMN) was developed. DMMN is a commercially available, bench-stable solid. The transnitrilation with DMMN avoids the use of toxic reagents and transition metals and occurs under mild reaction conditions, even for extremely

  开发了芳基格氏试剂或锂试剂的亲电氰化，由相应的芳基溴化物或碘化物原位生成，通过与二甲基丙二腈 (DMMN) 进行腈基转移。DMMN 是市售的、工作台稳定的固体。使用 DMMN 进行的腈基转移避免了使用有毒试剂和过渡金属，并且在温和的反应条件下发生，即使对于空间位阻非常大的底物也是如此。由定向邻位锂化产生的芳基锂物质的腈基转腈作用使净 CH 氰化成为可能。Thorpe 型亚胺加合物在反应中的中介作用是通过从淬灭反应中分离相应的酮来支持的。计算研究支持亚胺加合物逆向索普碎裂的能量有利性。
• Tetracyclic lactam derivatives and uses thereof
  申请人：Jagtap Prakash

  公开号：US20050261288A1

  公开（公告）日：2005-11-24

  The present invention relates to Tetracyclic Lactam Derivatives, compositions comprising an effective amount of a Tetracyclic Lactam Derivative and methods for treating or preventing an inflammatory disease, a reperfusion injury, an ischemic condition, renal failure, diabetes, a diabetic complication, a vascular disease, reoxygenation injury resulting from organ transplantation, Parkinson's disease, or cancer, comprising administering to an animal in need thereof an effective amount of a Tetracyclic Lactam Derivative.

  本发明涉及四环内酰胺衍生物，包括有效量的四环内酰胺衍生物的组合物，以及治疗或预防炎症性疾病、再灌注损伤、缺血症状、肾衰竭、糖尿病、糖尿病并发症、血管疾病、器官移植引起的再氧化损伤、帕金森病或癌症的方法，包括向需要的动物施用有效量的四环内酰胺衍生物。
• [EN] SMALL MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR ACTIVITY AND/OR EXPRESSION AND USES THEREOF<br/>[FR] INHIBITEURS À PETITES MOLÉCULES DE L'ACTIVITÉ ET/OU DE L'EXPRESSION DU RÉCEPTEUR DES ANDROGÈNES ET UTILISATIONS CORRESPONDANTES
  申请人：UNIV ARIZONA

  公开号：WO2020123670A1

  公开（公告）日：2020-06-18

  This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a piperazine (or similar) structure which function as antagonists of androgen receptor activity, and their use as therapeutics for the treatment of cancer (e.g., castration-resistant prostate cancer) and other conditions characterized with androgen receptor activity and/or androgen receptor expression.

  这项发明属于药物化学领域。具体地说，该发明涉及一类新型小分子，其具有哌嗪（或类似）结构，能够作为雄激素受体活性的拮抗剂，并且它们被用作治疗癌症（例如去势抵抗性前列腺癌）和其他与雄激素受体活性和/或雄激素受体表达相关的疾病的治疗药物。